Day: June 2, 2022

Immatics Announces First Quarter 2022 Financial Results and Business Update

Written by Customer Service on June 2, 2022. Posted in Earnings Releases And Operating Results.

ACTengine® IMA203: First patients treated at RP2D in Phase 1b cohort A with IMA203 monotherapy as well as Phase 1b cohort B with IMA203/checkpoint inhibitor combination. IND for Phase 1b cohort C with 2nd-generation IMA203CD8 granted Phase 1 clinical trial initiated with the first T cell engaging receptor TCER® IMA401 targeting MAGEA4/8 for patients with recurrent and/or refractory solid tumors New multi-program collaboration with Bristol Myers Squibb to develop allogeneic TCR-T/CAR-T programs; agreement includes $60 million upfront payment to Immatics and up to $700 million per program in milestone payments as well as tiered royalties Bristol Myers Squibb and Immatics are also including an additional target to their autologous TCR-T collaboration signed in 2019, Immatics to receive an upfront payment of $20 million and eligibility...

Lands’ End Announces First Quarter Fiscal 2022 Results

Written by Customer Service on June 2, 2022. Posted in Earnings Releases And Operating Results.

DODGEVILLE, Wis., June 02, 2022 (GLOBE NEWSWIRE) — Lands’ End, Inc. (NASDAQ: LE) today announced financial results for the first quarter ended April 29, 2022. Jerome Griffith, Chief Executive Officer, stated, “Despite revenue pressure from global supply chain issues and the impact of inflation on the consumer, we achieved our profit expectations. We continued to successfully execute on our strategic initiatives and are encouraged by the performance of our Outfitters business, which increased 33%, and by our expanding Third Party business, which increased 83%. I am very proud of our team, whose performance, in light of these headwinds, has reinforced my confidence in our long-term strategy, as we continue to capitalize on our digitally-led business model to advance our four strategic pillars of growth.” First Quarter Financial Highlights:For...

Duluth Holdings Inc. Announces First Quarter 2022 Financial Results

Written by Customer Service on June 2, 2022. Posted in Earnings Releases And Operating Results.

Duluth by Duluth Trading Co. Duluth by Duluth Trading Co.AKHG by Duluth Trading Co. AKHG by Duluth Trading Co.Net Sales of $122.9 million Gross Margin increases 470 basis points to 54.6% Launches new Duluth by Duluth Trading Co. logo and Rebrands Alaskan Hardgear as AKHG Reaffirmed Fiscal 2022 outlook for Net Sales, EPS and Adjusted EBITDA MOUNT HOREB, Wis., June 02, 2022 (GLOBE NEWSWIRE) — Duluth Holdings Inc. (dba, Duluth Trading Company) (“Duluth Trading” or the “Company”) (NASDAQ: DLTH), a lifestyle brand of men’s and women’s workwear, casual wear, outdoor apparel and accessories, today announced its financial results for the fiscal first quarter ended May 1, 2022. Highlights for the First Quarter Ended May 1, 2022Net sales of $122.9 million compared to $133.4 million in the prior year first quarter Gross margin improved...

Suominen launches a nonwoven made with recycled paper

Written by Customer Service on June 2, 2022. Posted in Public Companies.

Suominen Corporation’s press release on June 2, 2022 at 1:00 p.m. (EEST) Suominen further strengthens its position as the frontrunner in sustainable nonwovens by launching HYDRASPUN® Circula, the market’s first ever nonwoven made with recycled paper. HYDRASPUN® Circula is biodegradable, plastic-free and can be used in multiple applications. The product was created in cooperation with Codi Group, one of Europe’s leading wet wipe producers. Drawing from both parties’ industry expertise, the new product offers a variety of applications to meet consumers’ daily needs. “It is important for Suominen to continuously develop new sustainable products to be able to offer even more choices to our customers. HYDRASPUN® Circula is a perfect example of how we can develop our nonwovens with innovations and more sustainable raw materials. HYDRASPUN® Circula...

Reviva Pharmaceuticals to Participate in the 2022 BIO International Convention

Written by Customer Service on June 2, 2022. Posted in Public Companies.

CUPERTINO, Calif.,, June 02, 2022 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), cardiovascular, metabolic, and inflammatory diseases, today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will participate in the 2022 BIO International Convention, to be held June 13-16 in San Diego, CA. Please see additional details below: 2022 BIO International Convention – (Hybrid) Date: Tuesday, June 14, 2022Time: 12:15 p.m. (PT)/ 3:15 p.m. (ET)Location: San Diego, CAFormat: Company Presentation & One-On-One MeetingsRegistration: Click Here The Reviva team invites registered attendees to participate via...

Genetron Health Releases 10 New Research Results at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

Written by Customer Service on June 2, 2022. Posted in Public Companies.

BEIJING, June 02, 2022 (GLOBE NEWSWIRE) — Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced the release of 10 research results at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting. Based on Genetron Health’s patented One-Step™ Seq Method and core products such as Onco PanScan™, the results aimed to contribute to the scientific research and clinical practice of full-cycle cancer management. These studies involved an in-depth analysis of the Chinese population and focused on analyzing the characteristics of gene mutations and fusion mapping of multiple cancer types, including lung cancer and...

Canadian Credit Market Surges as Economy Recovers

Written by Customer Service on June 2, 2022. Posted in Public Companies.

Chart 1: Canadian Credit Industry Indicator A lower CII number compared to the prior period represents a decline in credit health, while a higher number reflects an improvement. The CII number needs to be looked at in relation to the previous period(s) and not in isolation. In March 2022, the CII of 105.3 represented an improvement in credit health compared to the same month prior year (March 2021) and a slight decline in credit health compared to the prior month (February 2021).In Q1 2022, TransUnion’s Credit Industry Indicator increased 22 points year-on-year, returning to pre-pandemic levels, as all underlying factors improved over the period Under strengthening economic fundamentals, credit participation grew and originations and balances increased as consumers and lenders became more active Rising inflation and interest rates...

GDS to Hold Annual General Meeting on June 30, 2022

Written by Customer Service on June 2, 2022. Posted in Public Companies.

SHANGHAI, China, June 02, 2022 (GLOBE NEWSWIRE) — GDS Holdings Limited (“GDS Holdings,” “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China, today announced that it will hold its 2022 Annual General Meeting of Shareholders (the “AGM”) at Beijing Meeting Room, F5, Building C, Sunland International, No. 999 Zhouhai Road, Pudong, Shanghai, P.R.C. at 4:00 p.m. (China Standard Time) on June 30, 2022 (which is 4:00 a.m. (Eastern Daylight Time) on June 30, 2022). Holders of the Company’s ordinary shares and Series A convertible preferred shares listed in the register of members of the Company at the close of business on June 1, 2022 (China Standard Time) are entitled to receive notice of, and vote at, the AGM or at any adjournment that may take place. Beneficial...

Centessa Pharmaceuticals Makes Strategic Decision to Discontinue Clinical Development of Lixivaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Written by Customer Service on June 2, 2022. Posted in Public Companies.

– Decision based on reassessment of commercial potential of lixivaptan following recent observation of ALT/AST elevations in ALERT Study – – Discontinuation of lixivaptan development expected to significantly reduce cash burn and extend cash runway into 2026 – – Company continues to focus on the development of its innovative high impact rare disease and immuno-oncology pipeline of investigational medicines for patients – BOSTON and LONDON, June 02, 2022 (GLOBE NEWSWIRE) — Centessa Pharmaceuticals plc (Nasdaq: CNTA), today announced that it has made the strategic decision to discontinue development of lixivaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) including both the Phase 3 ACTION Study and the open-label ALERT Study. The decision is based on a thorough reassessment of the...

TRX Gold Confirms Northeast Extension of the Buckreef Gold Main Zone and Expands Exploration Program With Additional Drill Rig

Written by Customer Service on June 2, 2022. Posted in Public Companies.

Drill Results Include 28.0 m @ 3.27 g/t, Including 7.0m @ 7.27 g/tTable 1.1 Buckreef Main Zone Northeast Extension (NEE) Assay Results. *Figure 1 Map Showing Mineralization Extension and Location of Drill Results at Buckreef Main Zone Northeast Extension (Drone Base Image Date – May 2021. Oxide Pit outline as of April 2022).Figure 2 Section 30 – Looking to North-East.Figure 3 Section 28 – Looking to North-East.Figure 4 Buckreef Gold Drill Rig in Northeast Extension.Figure 5 Buckreef Gold Open Pit (May 2022) with view towards North-East and Drill Rig Location.TORONTO, June 02, 2022 (GLOBE NEWSWIRE) — TRX Gold Corporation (TSX:TNX) (NYSE American:TRX) (the “Company” or “TRX Gold”) is pleased to announce a 250 meter (m) extension of the Buckreef Gold Main Zone to 1.8 Kilometers (kms) and positive assay...

Day: June 2, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice